BACKGROUND: The M-type phospholipase A 2 receptor (PLA 2R) was recently identified as a candidate antigen in 70% of cases of idiopathic membranous nephropathy, a common form of the nephrotic syndrome. The nature of antigens involved in other idiopathic and secondary membranous nephropathies remains unclear. METHODS: We searched for antibodies against bovine serum albumin and circulating bovine serum albumin by means of enzyme-linked immunosorbent assay and Western blotting in serum specimens obtained from 50 patients with membranous nephropathy and 172 controls. The properties of immunopurified circulating bovine serum albumin obtained from serum specimens were analyzed with the use of two-dimensional sodium dodecyl sulfate-polyacrylamide-g...
Primary membranous nephropathy (MN) is the leading cause of nephrotic syndrome in adults. Discovery ...
International audienceBACKGROUND: Idiopathic membranous nephropathy, a common form of the nephrotic ...
The discovery in 2009 of the M-type phospholipase A2 receptor (PLA2R) as the primary target in membr...
International audienceAntibodies to neutral endopeptidase, a podocyte protein, are responsible for r...
International audienceAntibodies to neutral endopeptidase, a podocyte protein, are responsible for r...
International audienceAntibodies to neutral endopeptidase, a podocyte protein, are responsible for r...
International audienceOver the past few years, considerable advances have been made in our understan...
International audienceOver the past few years, considerable advances have been made in our understan...
International audienceOver the past few years, considerable advances have been made in our understan...
Insights from experimental studies have been recently translated into substantial advances in unders...
Background. M-type phospholipase A2 receptor (PLA2R) is the first autoantigen responsible for idiopa...
The M-type phospholipase A2 receptor (PLA2R) is the major target antigen in idiopathic membranous ne...
The phospholipase A 2 receptor (PLA 2R) is the major target antigen in idiopathic membranous nephrop...
Primary membranous nephropathy (MN) is the leading cause of nephrotic syndrome in adults. Discovery ...
AIM: The phospholipase A2 receptor (PLA2R) is the major target antigen in idiopathic membranous neph...
Primary membranous nephropathy (MN) is the leading cause of nephrotic syndrome in adults. Discovery ...
International audienceBACKGROUND: Idiopathic membranous nephropathy, a common form of the nephrotic ...
The discovery in 2009 of the M-type phospholipase A2 receptor (PLA2R) as the primary target in membr...
International audienceAntibodies to neutral endopeptidase, a podocyte protein, are responsible for r...
International audienceAntibodies to neutral endopeptidase, a podocyte protein, are responsible for r...
International audienceAntibodies to neutral endopeptidase, a podocyte protein, are responsible for r...
International audienceOver the past few years, considerable advances have been made in our understan...
International audienceOver the past few years, considerable advances have been made in our understan...
International audienceOver the past few years, considerable advances have been made in our understan...
Insights from experimental studies have been recently translated into substantial advances in unders...
Background. M-type phospholipase A2 receptor (PLA2R) is the first autoantigen responsible for idiopa...
The M-type phospholipase A2 receptor (PLA2R) is the major target antigen in idiopathic membranous ne...
The phospholipase A 2 receptor (PLA 2R) is the major target antigen in idiopathic membranous nephrop...
Primary membranous nephropathy (MN) is the leading cause of nephrotic syndrome in adults. Discovery ...
AIM: The phospholipase A2 receptor (PLA2R) is the major target antigen in idiopathic membranous neph...
Primary membranous nephropathy (MN) is the leading cause of nephrotic syndrome in adults. Discovery ...
International audienceBACKGROUND: Idiopathic membranous nephropathy, a common form of the nephrotic ...
The discovery in 2009 of the M-type phospholipase A2 receptor (PLA2R) as the primary target in membr...